MD - MEDNAX, Inc.
| Previous Close | 47.09 |
| Open | 47.18 |
| Bid | 46.71 x 2200 |
| Ask | 54.84 x 800 |
| Day's Range | 46.55 - 47.35 |
| 52 Week Range | 40.56 - 63.04 |
| Volume | 1,083,315 |
| Avg. Volume | 780,429 |
| Market Cap | 4.321B |
| Beta | 0.00 |
| PE Ratio (TTM) | 12.61 |
| EPS (TTM) | 3.71 |
| Earnings Date | Oct 30, 2018 - Nov 5, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 51.38 |
- GlobeNewswire•21 hours ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mednax, Inc. - MD
NEW YORK, Aug. 17, 2018-- Pomerantz LLP is investigating claims on behalf of investors of Mednax, Inc.. Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ...
- GlobeNewswire•2 days ago
CLASS ACTION UPDATE for MD and NWL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, Aug. 16, 2018-- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving ...
- ACCESSWIRE•2 days ago
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against MEDNAX, Inc. (MD) and Lead Plaintiff Deadline - September 10, 2018
NEW YORK, NY / ACCESSWIRE / August 16, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against MEDNAX, Inc. ("Mednax" or the "Company") (NYSE: MD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Mednax securities between February 4, 2016 to July 27, 2017(the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
- ACCESSWIRE•3 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mednax, Inc. - MD
NEW YORK, NY / ACCESSWIRE / August 15, 2018 / Pomerantz LLP is investigating claims on behalf of investors of Mednax, Inc. ("Mednax" or the "Company") (MD). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The investigation concerns whether Mednax and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
- GlobeNewswire•3 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, HAIR and ACAD
NEW YORK, Aug. 15, 2018-- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead ...
- Thomson Reuters StreetEvents•4 days ago
Edited Transcript of MD earnings conference call or presentation 2-Aug-18 2:00pm GMT
Q2 2018 MEDNAX Inc Earnings Call
- GlobeNewswire•6 days ago
SHAREHOLDER ALERT: MRCY GLNCY GLCNF MD FPI FIZZ SBGL ACAD ABBV TTPH RMTI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, Aug. 12, 2018-- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead ...
- Business Wire•7 days ago
DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Those Who Have Losses in Excess of $100,000 from Investment in Mednax, Inc. to Contact the Firm
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Florida on behalf of purchasers of Mednax, Inc. (MD) (“Mednax” or the “Company”) securities during the period between February 4, 2016 to July 27, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until September 10, 2018 to seek appointment as lead plaintiff.
- GlobeNewswire•7 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mednax, Inc. - MD
Pomerantz LLP is investigating claims on behalf of investors of Mednax, Inc. (“Mednax” or the “Company”) (NYSE: MD). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. On April 20, 2017, Mednax announced negative financial results for the first quarter of 2017, including missed earnings. Mednax cited negative trends including “payor mix” degradation, lower volume of newborn infant patients, and wage inflation, with half of the financial impact related to business in North Carolina and Texas. On this news, Mednax’s stock price fell $5.39 per share, or 8.1%, to close at $61.30 per share on April 20, 2017. Then, on July 28, 2017, during its second-quarter earnings call with investors and analysts, Mednax announced that the Company had failed to complete any acquisitions of anesthesiologist practices during the quarter and that any future anesthesiologist acquisitions were unlikely, citing the “challenging” payor mix combined with “continued .
- GlobeNewswire•8 days ago
New Research Coverage Highlights EOG Resources, Zimmer Biomet, MGIC Investment, EPR Properties, Guess?, and Mednax — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Aug. 10, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of EOG ...
- GlobeNewswire•9 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, FIZZ, TTPH, FB and HMNY
NEW YORK, Aug. 09, 2018-- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead ...
- GlobeNewswire•9 days ago
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against MEDNAX, Inc. (MD) and Lead Plaintiff Deadline – September 10, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against MEDNAX, Inc. ("Mednax" or the "Company") (NYSE:MD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Mednax securities between February 4, 2016 to July 27, 2017 (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/md. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
- ACCESSWIRE•10 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mednax, Inc. - MD
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Pomerantz LLP is investigating claims on behalf of investors of Mednax, Inc. ("Mednax" or the "Company") (MD). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The investigation concerns whether Mednax and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
- GlobeNewswire•12 days ago
SHAREHOLDER ALERT: MD ORA SBGL NWL PCG ACAD RMTI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, Aug. 06, 2018-- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead ...
- ACCESSWIRE•14 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mednax, Inc. - MD
NEW YORK, NY / ACCESSWIRE / August 4, 2018 / Pomerantz LLP is investigating claims on behalf of investors of Mednax, Inc. ("Mednax" or the "Company") (MD). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The investigation concerns whether Mednax and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
- GlobeNewswire•15 days ago
CLASS ACTION UPDATE for MRCY, MD and FPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, Aug. 03, 2018-- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving ...
- ACCESSWIRE•15 days ago
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against MEDNAX, Inc. (MD) and Lead Plaintiff Deadline - September 10, 2018
NEW YORK, NY / ACCESSWIRE / August 3, 2018 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against MEDNAX, Inc. ("Mednax" or the "Company") (NYSE: MD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Mednax securities between February 4, 2016 to July 27, 2017(the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
- GlobeNewswire•16 days ago
SHAREHOLDER ALERT: MD ANW QCOM FIZZ NWL GOGO ACAD FB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, Aug. 02, 2018-- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead ...
- American City Business Journals•16 days ago
Longtime CFO of Mednax to retire
Mednax Inc. announced that CFO and treasurer Vivian Lopez-Blanco has decided to retire. The Sunrise-based medical practice ownership company (NYSE: MD) said that Lopez-Blanco will stay on until it finds a replacement, and remain for a transitional period thereafter. Lopez-Blanco has been with Mednax since 2008, starting as VP and treasurer.
- Associated Press•16 days ago
Mednax: 2Q Earnings Snapshot
The Sunrise, Florida-based company said it had profit of 85 cents per share. Earnings, adjusted for amortization costs and stock option expense, were $1.07 per share. The results exceeded Wall Street expectations. ...
- Business Wire•16 days ago
MEDNAX Reports Second Quarter GAAP EPS of $0.85; Adjusted EPS of $1.07
Expands Financial and Operational Improvement Targets
- ACCESSWIRE•17 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mednax, Inc. - MD
NEW YORK, NY / ACCESSWIRE / August 1, 2018 / Pomerantz LLP is investigating claims on behalf of investors of Mednax, Inc. ("Mednax" or the "Company") (MD). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The investigation concerns whether Mednax and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
- GlobeNewswire•17 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, ORA and PCG
NEW YORK, Aug. 01, 2018-- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead ...
- GlobeNewswire•17 days ago
Hagens Berman Reminds Investors in Mednax, Inc. (NYSE: MD) of the September 10, 2018 Securities Class Action Lead Plaintiff Deadline
SAN FRANCISCO, Aug. 01, 2018-- Hagens Berman Sobol Shapiro LLP reminds investors in Mednax, Inc. of the September 10, 2018 Lead Plaintiff deadline in the pending securities class action. If you purchased ...
- GlobeNewswire•17 days ago
SHAREHOLDER ALERT: MD ANW DB QCOM PCG ACAD RMTI FB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, Aug. 01, 2018-- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead ...